Can Valsartan (angiotensin II receptor antagonist) cause hives?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Valsartan Cause Hives?

Yes, valsartan can cause hives (urticaria) as a cutaneous adverse reaction, though this is relatively rare. 1, 2 Angiotensin receptor blockers (ARBs) like valsartan have been documented to cause various skin reactions including exanthematous drug eruptions and, in some cases, angioedema and urticaria.

Evidence of Valsartan-Related Skin Reactions

Documented Cases

  • A case report documented a 47-year-old man who developed diffuse, itchy erythematous maculopapular eruption (drug exanthem) after taking valsartan for 10 days 1
  • Another case report described a 71-year-old woman who experienced angioedema and a photosensitive pruritic rash after 3 months of valsartan therapy 2

Mechanism and Risk Factors

Valsartan-induced skin reactions appear to be hypersensitivity reactions, similar to those seen with other antihypertensive medications. While the exact mechanism is not fully understood, these reactions likely involve immune-mediated processes.

Risk factors may include:

  • Prior history of drug allergies
  • Concurrent use of other medications
  • Genetic predisposition to drug hypersensitivity

Clinical Presentation and Management

Presentation

Valsartan-induced hives typically present as:

  • Pruritic (itchy) raised wheals
  • May be accompanied by angioedema in some cases
  • Can appear anywhere on the body
  • Usually develops within days to months after starting therapy

Management

If hives develop while taking valsartan:

  1. Discontinue valsartan - This is the primary intervention 2
  2. Antihistamine therapy:
    • Second-generation H1-antihistamines (e.g., cetirizine 10mg, fexofenadine 180mg) as first-line treatment 3
    • Can increase dose up to 4 times the standard dose if needed 3
  3. For severe reactions:
    • Short course of oral corticosteroids may be necessary
    • If angioedema affects the airway, epinephrine is the first-line treatment 4

Alternative Antihypertensive Options

For patients who develop hives or other hypersensitivity reactions to valsartan, alternative antihypertensive medications from different classes should be considered:

  • Calcium channel blockers
  • Beta-blockers
  • Diuretics (with caution, as some patients with sulfonamide antibiotic allergies may cross-react with thiazide diuretics) 5
  • ACE inhibitors (with caution, as they have a higher rate of angioedema than ARBs) 6

Important Considerations

Monitoring

Patients starting valsartan should be advised to monitor for:

  • Development of skin rashes or hives
  • Swelling of the face, lips, tongue, or throat
  • Difficulty breathing or swallowing

Severity Assessment

While most skin reactions to valsartan are mild to moderate, some can be severe:

  • If angioedema affects the airway, this constitutes a medical emergency 4
  • If hives are accompanied by respiratory distress, vomiting, or lethargy, treat as anaphylaxis 3

Cross-Reactivity

There may be cross-reactivity between different ARBs, so caution is warranted when switching to another medication in the same class after a reaction to valsartan 6.

Conclusion

While generally well-tolerated, valsartan can cause hives and other cutaneous adverse reactions in some patients. Prompt recognition and appropriate management are essential to prevent progression to more severe manifestations.

References

Research

Exanthematous drug eruption due to valsartan.

Cutaneous and ocular toxicology, 2012

Guideline

Chronic Urticaria Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A drug safety evaluation of valsartan.

Expert opinion on drug safety, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.